Premier Alternatives

OxTium Technology

Shenzhen, China · Founded 2022 · Privately Held (backing)

Developer of AI-driven bioscience platforms aims to advance computational intelligence in life science research and industrial applications. OxTium Technology is based in Shenzhen, China and was founded in 2022. Its last reported valuation was $21.1 million in Jan 2024. It has raised $3.9 million.

Last reported valuation
$21.1M
Oct 2026
Priced at
—
Total raised
$3.9M
Last round
—

OxTium Technology key facts

as of Oct 2026
  • Developer of AI-driven bioscience platforms aims to advance computational intelligence in life science research and industrial applications.
  • OxTium Technology is valued at approximately $21.1M as of Oct 2026 (last reported valuation).
  • It has raised $3.9M; the latest was Early Stage VC in Nov 2025.
  • Notable investors include HSG (Hong Kong), Shenzhen Nanshan Strategic Emerging Industry Investment, Shenzhen CDF Capital, Jiangxi Financial Holding Group, Shenzhen Lihe Science and Technology Innovation — 6 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$21.1M

OxTium Technology's last reported valuation, Jan 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of OxTium Technology with a free account
  • ·Watch OxTium Technology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

OxTium Technology funding rounds

No rounds on record

No funding rounds for OxTium Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

OxTium Technology valuation

OxTium Technology's last reported valuation was $21.1 million in Jan 2024. No priced round, secondary trade or fund mark has surfaced since.

OxTium Technology investors

6 investors are on record for OxTium Technology, including HSG (Hong Kong), Shenzhen Nanshan Strategic Emerging Industry Investment, Shenzhen CDF Capital and Jiangxi Financial Holding Group.

About OxTium Technology

Developer of AI-driven bioscience platforms aims to advance computational intelligence in life science research and industrial applications. The company's offerings feature the AI research suite for cloud-native scientific exploration, the multi-omics large model framework for cross-modal biological interpretation, and an intelligent research ecosystem integrating pre-trained foundation models, enabling breakthroughs in precision diagnostics, industrial biomanufacturing, genomic breeding, and environmental bioengineering.

Sector
Healthcare
HQ
Shenzhen, China
Founded
2022
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.